Key Segments:
By Component
-
AI Software Platforms
-
Autonomous Laboratory Hardware
-
Cloud & Computing Infrastructure
-
Professional & Integration Services
-
Others
By Technology
-
Machine Learning
-
Deep Learning
-
Generative AI
-
Robotic Laboratory Automation
-
Others
By Application
-
Target Identification
-
Lead Discovery & Optimization
-
ADMET Prediction
-
Drug Repurposing
-
Others
By End User
-
Pharmaceutical Companies
-
Biotechnology Companies
-
Contract Research Organizations
-
Academic & Research Institutes
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The Autonomous Drug Discovery Market was valued at USD 2.85 Billion in 2025.
The market is projected to reach USD 15.70 Billion by 2035.
The market is anticipated to expand at a CAGR of 18.60% during the forecast period.
North America dominated the global Autonomous Drug Discovery Market in 2025, accounting for 45.00% of total revenue.
AI Software Platforms accounted for the largest revenue share of 36.00% in 2025.